Home
Site Map
About Roche
Contact Us
Help
Clinical. Credible. Convenient.
Not a Member?
Log In
Forgot Password?
Instant Access Code
Sign Up
»
E-mail:
Password:
Code:
Remember Me
Log In
»
Go
»
Main Menu
Influenza Home
News
Clinical Trials
Education
Product Information
TAMIFLU (oseltamivir phosphate)
Publications
Other Resources
Influenza Quick Sort
More Therapeutic Areas
Select an Area
Hepatology
Oncology
Osteoporosis
Rheumatoid Arthritis
More Roche Product Info
Select a Product
Boniva
Kytril
Pegasys
Tamiflu
Xeloda
Other Roche Products
Meeting Calendar
Select a link below to view details.
June 2010
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Search RocheExchange
Please use TWO or more words to qualify your search.
Example: Where can I find information about flu screening?
Search
»
1
FEATURED STORY
CDC: H1N1
Flu Guidance
View Full Story »
2
FEATURED STORY
FluSTAR™
System for Tracking and Reporting Flu
View Full Story »
3
FEATURED STORY
Compounding TAMIFLU Oral Solution
View Full Story »
Mouse over to view:
1
2
3
Influenza Quick Links:
Disease / Diagnosis
Press Releases
Surveillance
Featured Story Archive
Treatment / Prevention
Influenza Guidelines
Pandemic Influenza
The Latest Influenza News
Aug 26, 2010
TopAbstracts in Influenza 08/26/2010
TopAbstracts - Past 28 days Clinical features of hospitalised children with 2009 H1N1 influenza virus infection - (Eur J Pediatr) Safety of oseltam...
View Full Story »
Aug 26, 2010
Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza
Background: Peramivir, a sialic acid analogue, is a selective inhibitor of neuraminidases produced by influenza A and B viruses. We evaluated the effi...
View Full Story »
Aug 25, 2010
Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the united states during an influenza pandemic
Background: Secondary bacterial infections (especially pneumococcal infections) were a major cause of death during prior influenza pandemics. One stra...
View Full Story »
Aug 25, 2010
Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens
A licensed, inactivated vaccine based on a low pathogenic avian influenza virus strain (H5N2) was evaluated in layer hens kept under field conditions ...
View Full Story »
View all News headlines >>